Daofeng Dai
Impact in
-
- MicroRNA in disease regulation
Papers in
-
- Epigenetics and DNA Methylation 2
- RNA modifications and cancer 2
- Genomics, phytochemicals, and oxidative stress 1
- Surgery 2
- Co-authors
- Lisong Teng (3 shared papers)Yan Yang (3 shared papers)Jing Ye (3 shared papers)Wenjing Qin (1 shared paper)Aifa Tang (2 shared papers)Yawen Tan (1 shared paper)Zixin Deng (2 shared papers)Yuanping Xiong (4 shared papers)
- Journals
- Pathology & Oncology Research (2 papers)Frontiers in Microbiology (2 papers)Journal of Translational Medicine (2 papers)Frontiers in Oncology (1 paper)Microbial Cell Factories (1 paper)
- Partner nations
- ChinaUnited States
In The Last Decade
Daofeng Dai
12 papers receiving 305 citations
Peers
Comparison fields: 5 of 52
- Cancer Research 66
- Otorhinolaryngology 11
- Molecular Biology 167
- Biotechnology 17
- Surgery 77
Countries citing papers authored by Daofeng Dai
This map shows the geographic impact of Daofeng Dai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daofeng Dai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daofeng Dai more than expected).
Fields of papers citing papers by Daofeng Dai
This network shows the impact of papers produced by Daofeng Dai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daofeng Dai. The network helps show where Daofeng Dai may publish in the future.
Co-authors
The 25 scholars most cited alongside Daofeng Dai, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 101 | |
| 2 | 2019 | 54 | |
| 3 | 2022 | 40 | |
| 4 | 2021 | 28 | |
| 5 | 2016 | 22 | |
| 6 | 2021 | 21 | |
| 7 | 2021 | 15 | |
| 8 | 2013 | 13 | |
| 9 | 2022 | 4 | |
| 10 | 2021 | 3 | |
| 11 | 2024 | 3 | |
| 12 | 2018 | 2 |
About Daofeng Dai
Daofeng Dai is a scholar working on Molecular Biology, Surgery, Cancer Research, Pathology and Forensic Medicine and Pollution, having authored 12 papers that have together received 306 indexed citations. Recurring topics across this work include Epigenetics and DNA Methylation (2 papers), RNA modifications and cancer (2 papers), Pneumocystis jirovecii pneumonia detection and treatment (1 paper), Ferroptosis and cancer prognosis (1 paper), Lung Cancer Research Studies (1 paper), Cancer Genomics and Diagnostics (1 paper), Genomics, phytochemicals, and oxidative stress (1 paper) and Peptidase Inhibition and Analysis (1 paper). The work is most often cited by research in Cancer Research (66 citations), Otorhinolaryngology (11 citations), Molecular Biology (167 citations), Biotechnology (17 citations) and Surgery (77 citations). Daofeng Dai has collaborated with scholars based in China and United States. Frequent co-authors include Lisong Teng, Yan Yang, Jing Ye, Wenjing Qin, Aifa Tang, Yawen Tan, Zixin Deng, Yuanping Xiong, Lifeng Li and Jingdan Liang. Their work appears in journals such as Pathology & Oncology Research, Frontiers in Microbiology, Journal of Translational Medicine, Frontiers in Oncology and Microbial Cell Factories.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.